CA-SCIENTIST.COM
9.4.2024 13:56:31 CEST | Business Wire | Press release
Scientist.com, the pharmaceutical industry’s leading R&D marketplace, announced today that Sanguine Biosciences, a leading biospecimen provider that connects researchers to the biospecimens they need with a direct-to-donor model to accelerate precision medicine and cell and gene therapy research and development, has successfully completed a VERIF.i® on-site assessment. VERIF.i helps Scientist.com marketplace suppliers demonstrate internal processes and adherence to best practices to both existing and potential new clients.
“Through direct-to-donor engagement, Sanguine continues to amass one of the industry’s largest collections of ethically procured collections that includes extensive data about the biospecimens,” stated Sanguine CEO Brian Neman. “Scientist.com’s VERIF.i program enables us to further demonstrate the exceptional quality of our biospecimen and biorepository services and the commitment of our team to bridge the gap between donors and researchers.”
Sanguine supports translational, clinical, and cell and gene therapy research, and their services include prospective in-home biospecimen collection directly from their donor network, apheresis products including leukopaks and LeukoLots™, biospecimen inventory, and biorepository services. Their research products and services facilitate advanced therapy development programs from discovery to manufacturing.
“Human biological samples increasingly represent critical tools in the drug discovery and development process, but researchers in the life sciences often have difficulty finding high-quality, ethically sourced human samples,” stated Matt McLoughlin, SVP of Categories & Compliance at Scientist.com. “VERIF.i was developed to create a standardized process that helps researchers and sample providers ensure that the samples used in research meet their expected quality and ethical standards.”
For more information on VERIF.i, visit https://www.scientist.com/verifi/
About Sanguine Biosciences
Sanguine Biosciences is accelerating the adoption of personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. By merging annotated patient biospecimens with real-world and analytical data, Sanguine delivers actionable biomarker discovery and validation studies that bridge the gap between patients and scientists working on innovative therapies. In supporting translational and clinical research at 30 of the top 40 global pharmaceutical and biotechnology companies, Sanguine has accelerated R&D and increased confidence in drug development and manufacturing pipelines. For the past four years, Sanguine has received the prestigious designation as a "Great Places to Work'' company. In 2023, Sanguine was designated on the Inc. 5000 America's Fastest Growing Private Companies list, Fortune Best Workplaces in BioPharma, and Fortune Best Small Workplaces. Visit sanguinebio.com to learn more.
About Scientist.com
Scientist.com is a privately held San Diego-based company on a mission to make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace that helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Through Scientist.com, scientists communicate directly with research experts at over 4,000 global laboratories to design and execute complex research experiments. Visit scientist.com to learn more.
Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409671820/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lenovo Powers Esports World Cup 2026 as a Founding Partner28.7.2026 11:00:00 CEST | Press release
Lenovo™ joins EWC 2026 as a Global Partner with expanded integration across competition technology at the world’s largest esports eventLenovo Legion™ desktop PCs and monitors will equip players, broadcast operations, training facilities, and festival experiences throughout Paris this summerFans can experience the latest Legion innovations, including the Legion Pro Rollable Concept, during the seven-week competition The Esports Foundation (EF) and Lenovo today announced an expanded partnership, with Lenovo becoming a Global Partner of the Esports World Cup 2026 (EWC) and powering the world’s largest esports event with its high-performance Legion gaming devices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712251027/en/ The EWC 2026 will be bringing the world’s largest esports event to Paris for the first time, welcoming more than 2,000 players, 200 esports teams and fans from over 100 countries between July 6 and August
Ten Finalists Announced for the Reply AI Film Festival, the International Competition Bringing Together Cinema and Artificial Intelligence28.7.2026 10:00:00 CEST | Press release
The jury, chaired by Gabriele Salvatores, will announce the winners in Venice on Sunday, 6 September. The Reply AI Film Festival returns for its third edition, reaffirming its role as a meeting point for cinema, creativity and artificial intelligence. The international competition created by Reply – open to creatives experimenting with new AI technologies and tools in the production of short films – has announced its ten finalists. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260728146486/en/ The international competition created by Reply – open to creatives experimenting with new AI technologies and tools in the production of short films – has announced its ten finalists. The festival will take place in Veniceduring the days of the 83rd Venice International Film Festival of La Biennale di Venezia. Selected from more than 3,000 short films submitted from 76 countries, the finalist works will take centre stage at the awards
USHIO Industry & Entertainment Announces Trademark Licensing Agreement for OSRAM-Branded Professional Technical Lighting Products28.7.2026 08:30:00 CEST | Press release
Agreement ensures continuity for customers while supporting USHIO Industry & Entertainment's business strategy USHIO Industry & Entertainment (USHIO INE) today announced the signing of a trademark licensing agreement with ams OSRAM, that enables the company to continue offering designated professional technical lighting products under the trusted OSRAM product brand. The agreement marks an important milestone following USHIO's acquisition of the former OSRAM Entertainment & Industry business and reinforces the company's commitment to ensuring continuity for customers, products and long-standing partnerships worldwide. For customers, the agreement provides continuity for professional technical lighting products that have earned a strong reputation across entertainment, cinema, industrial and other specialty lighting applications. These products will continue to be supported by USHIO Industry & Entertainment's global organization, technical expertise and customer service. "The signing of
Grindr for Equality Commits to Connecting 10M to HIV Prevention by 202827.7.2026 16:31:00 CEST | Press release
New report finds PrEP awareness is high but access is low, as global HIV funding shrinks Grindr steps up Today at the 2026 International AIDS Conference, Grindr for Equality committed to connecting ten million LGBTQ+ people to HIV prevention by 2028, leveraging its platform reach to advance the global effort to end HIV by 2030. The commitment is rooted in Closing the Gap, a new Grindr for Equality report drawing on survey data from Grindr users across ten countries. The central finding is consistent across countries: people know about PrEP but they are not taking it. The barrier is access and the funding that existed to address it is disappearing. "Connecting people is what Grindr does at a scale and in communities that traditional public health systems don't effectively reach," said George Arison, CEO and Chairman of Grindr (NYSE: GRND). "The global HIV response is losing critical funding at the exact moment we should be accelerating to end HIV by 2030. Grindr has the reach and the re
InterSystems Launches Data Studio AI Assistant to Accelerate Enterprise Data Exploration and Insights27.7.2026 16:00:00 CEST | Press release
New Generative AI extension simplifies how teams explore, analyze, and visualize enterprise data InterSystems, a creative data technology provider powering some of the world's most important applications, today announced the general availability of InterSystems Data Studio™ AI Assistant, a new generative AI-powered extension for InterSystems Data Studio that helps organizations more easily understand, navigate, query, and visualize data through natural language interactions. As organizations move from AI experimentation to production deployments, many are discovering that the greatest challenge is not the AI model itself, but providing AI systems with access to trusted, current, and business-ready information. Enterprise data is often fragmented across applications, databases, cloud services, files, data warehouses, and departmental silos, making it difficult for users and AI systems to generate reliable insights. “Organizations are increasingly looking for ways to turn their data into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom